The estimated Net Worth of Svai S Sanford is at least $31.9 ezer dollars as of 29 January 2015. Svai Sanford owns over 472 units of VIVUS stock worth over $30,583 and over the last 11 years Svai sold VVUS stock worth over $1,312.
Svai has made over 1 trades of the VIVUS stock since 2015, according to the Form 4 filled with the SEC. Most recently Svai sold 472 units of VVUS stock worth $1,312 on 29 January 2015.
The largest trade Svai's ever made was selling 472 units of VIVUS stock on 29 January 2015 worth over $1,312. On average, Svai trades about 94 units every 0 days since 2014. As of 29 January 2015 Svai still owns at least 65,559 units of VIVUS stock.
You can see the complete history of Svai Sanford stock trades at the bottom of the page.
Svai's mailing address filed with the SEC is 351 E. EVELYN AVENUE, , MOUNTAIN VIEW, CA, 94041.
Over the last 21 years, insiders at VIVUS have traded over $6,261,269 worth of VIVUS stock and bought 5,180,746 units worth $13,074,554 . The most active insiders traders include Tide Capital, Llc North Tid..., Alexander J Denner és Ernest Mario. On average, VIVUS executives and independent directors trade stock every 39 days with the average trade being worth of $35,394. The most recent stock trade was executed by John P. Amos on 1 March 2019, trading 11,000 units of VVUS stock currently worth $53,350.
VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.
VIVUS executives and other stock owners filed with the SEC include: